Rodger Novak Crispr Therapeutics Ag (CRSP) insider trading activity

CRSP Quotes by TradingView

Rodger Novak is President of CRISPR Therapeutics AG. Currently has a direct ownership of 573,007 shares of CRSP, which is worth approximately $25.9 Million. The most recent transaction as insider was on May 30, 2017, when has been sold 3,650 shares (Common Shares) at a price of $15.02 per share, resulting in proceeds of $54,823. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 573K
0% 3M change
0% 12M change
Total Value Held $25.9 Million

Rodger Novak Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 30 2017
SELL
Open market or private sale
$54,823 $15.02 p/Share
3,650 Reduced 0.3%
1,215,005 Common Shares
May 30 2017
BUY
Exercise of conversion of derivative security
$6,606 $1.81 p/Share
3,650 Added 0.3%
1,218,655 Common Shares
May 17 2017
SELL
Open market or private sale
$415,546 $16.03 p/Share
25,923 Reduced 2.09%
1,215,005 Common Shares
May 17 2017
BUY
Exercise of conversion of derivative security
$46,921 $1.81 p/Share
25,923 Added 2.05%
1,240,928 Common Shares
May 16 2017
SELL
Open market or private sale
$397,270 $16.5 p/Share
24,077 Reduced 1.94%
1,215,005 Common Shares
May 16 2017
BUY
Exercise of conversion of derivative security
$43,579 $1.81 p/Share
24,077 Added 1.91%
1,239,082 Common Shares
May 05 2017
SELL
Open market or private sale
$10,423 $16.92 p/Share
616 Reduced 0.05%
1,215,005 Common Shares
May 05 2017
BUY
Exercise of conversion of derivative security
$1,115 $1.81 p/Share
616 Added 0.05%
1,215,621 Common Shares
May 04 2017
SELL
Open market or private sale
$215,937 $16.37 p/Share
13,191 Reduced 1.07%
1,215,005 Common Shares
May 04 2017
BUY
Exercise of conversion of derivative security
$23,876 $1.81 p/Share
13,191 Added 1.06%
1,229,196 Common Shares
May 03 2017
SELL
Open market or private sale
$331,195 $16.34 p/Share
20,269 Reduced 1.64%
1,215,005 Common Shares
May 03 2017
BUY
Exercise of conversion of derivative security
$36,687 $1.81 p/Share
20,269 Added 1.61%
1,235,274 Common Shares
May 02 2017
SELL
Open market or private sale
$263,224 $16.53 p/Share
15,924 Reduced 1.29%
1,215,005 Common Shares
May 02 2017
BUY
Exercise of conversion of derivative security
$28,822 $1.81 p/Share
15,924 Added 1.28%
1,230,929 Common Shares
Apr 20 2017
SELL
Open market or private sale
$39,847 $17.37 p/Share
2,294 Reduced 0.19%
1,215,005 Common Shares
Apr 20 2017
BUY
Exercise of conversion of derivative security
$4,152 $1.81 p/Share
2,294 Added 0.19%
1,217,299 Common Shares
Apr 19 2017
SELL
Open market or private sale
$863,002 $18.09 p/Share
47,706 Reduced 3.78%
1,215,005 Common Shares
Apr 19 2017
BUY
Exercise of conversion of derivative security
$86,348 $1.81 p/Share
47,706 Added 3.64%
1,262,711 Common Shares
RN

Rodger Novak

President
Cambridge, MA

Track Institutional and Insider Activities on CRSP

Follow CRISPR Therapeutics AG and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRSP shares.

Notify only if

Insider Trading

Get notified when an Crispr Therapeutics Ag insider buys or sells CRSP shares.

Notify only if

News

Receive news related to CRISPR Therapeutics AG

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CRSP